Back to UBS Group AG UBS Group AG

MRKRMRKR
14 quarters

Position history for UBS Group AGUBS Group AG's holdings in MARKER THERAPEUTICS INC

UBS Group AG holds 8,150 shares of MRKR (MARKER THERAPEUTICS INC), worth $11,981 as of 2026-Q2. The position was decreased (-74.8% shares).

Current Value

$11,981

Current Shares

8,150

Total Value Change

+$7,999

Total Shares Change

+2,541

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
8,150
-74.8%
$11,9810.0%$1.47
0
2026-Q1
Decreased
32,369
-81.4%
$42,0800.0%$1.37
0
2025-Q4
Increased
174,026
+2903.6%
$259,2990.0%$1.47
25
2025-Q3
Increased
5,794
+262.1%
$5,1740.0%$0.93
17
2025-Q2
Decreased
1,600
-88.8%
$2,4480.0%$1.46
0
2025-Q1
New
14,311
-
$17,6030.0%$1.27
28
2024-Q4
Exited
0
-100.0%
$00.0%$3.34
0
2024-Q3
New
19,104
-
$53,8730.0%$2.90
32
2024-Q2
Exited
0
-100.0%
$00.0%$5.43
0
2024-Q1
New
427
-
$1,8360.0%$4.30
17
2023-Q4
Exited
0
-100.0%
$00.0%$5.50
0
2023-Q3
Decreased
93
-93.8%
$4220.0%$4.54
0
2023-Q2
Decreased
1,507
-73.1%
$4,6720.0%$3.06
0
2023-Q1
New
5,609
-
$3,9820.0%$0.78
22

Other major holders of MRKR: Alyeska Investment Group, L.P., Hudson Bay Capital Management LP, VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used